Insurers Off The Hook In BASF Synthroid Spat

Law360, New York (April 14, 2008, 12:00 AM EDT) -- An appeals court has done an about-face in an insurance-coverage action related to the marketing of synthetic thyroid drug Synthroid, ruling that a group of primary-insurance providers were not obligated to indemnify BASF AG for a multidistrict litigation settlement.

A three-judge panel of the U.S. Court of Appeals for the Seventh Circuit said Monday that a lower court was wrong to grant summary judgment to BASF allowing the company to recover damages from its umbrella insurers for their failure to defend and indemnify the company in...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.